Teva Pharmaceutical Industries ADR (TEVA) Stock Price, Quote & News

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 972 3 914 8213

Website: www.tevapharm.com

Address:

124 Dvora HaNevi’a St., Tel Aviv-Yafo, Israel

Hshshhssos Dec. 6 at 5:04 PM

$TEVA currently trading at 11x earnings after this hige rally. This can easily be a $50 stock within a few years. Improving the debt load, margin expansion, and growth of specialty products can easily see 3.45-3.60 eps. Fair base case multiple for a specilty pharma co is 15x earnings (sanofi, merck, gsk, etc) Question becomes what does TEVA do with FCF once debt load collapses. Dividends? Acquisitions? It has become very clear why druckenmiller has been loading the boat. Great time to be a TEVA shareholder.

1 · Reply

SdotRayborn Dec. 6 at 3:55 AM

$TEVA TEVA RISE some believe in omens over silly charts tick tock👀👀

0 · Reply

LakersandVRX Dec. 5 at 10:11 PM

$TEVA Rooster is waiting for this to tank (along with his followers). It would be nice if he was wrong. Not hating on Rooster but everyone needs a douse of humbling...once in a while.

1 · Reply

TRADEADDICTNOMORE Dec. 5 at 6:49 PM

$TEVA thi

0 · Reply

SdotRayborn Dec. 5 at 6:37 PM

$TEVA nice

0 · Reply

WAJeff Dec. 5 at 6:01 PM

$TEVA Just observed that Druck's #3 position is also making a mammoth move (52.4% last three months, 52 week high today). You may just remember getting burned in this after 2015 but it could plug a gap to $37, a level not seen since November 2016.

0 · Reply

thinkandpick Dec. 5 at 5:23 PM

$TEVA Most investors know the popular Israeli stocks such as $TEVA $CYBR $PERI $SEDG $WIX but they do not know Silynxcom (SYNX). SYNX is an unknown and dirt-cheap Israeli company of the defense industry that recently expanded into the drone detection technology market: https://seekingalpha.com/instablog/526931-value-digger/6231090-silynxcom-ltd-undiscovered-debt-free-very-low-valuation-and-big-growth-potential

0 · Reply

JarvisFlow Dec. 5 at 3:02 PM

Scotiabank updates rating for Teva Pharmaceutical Indus ( $TEVA ) to Outperform, target set at 35.

0 · Reply

OfficialStocktwitsUser Dec. 5 at 12:46 PM

$TEVA RSI: 72.53, MACD: 1.5816 Vol: 1.29, MA20: 25.49, MA50: 22.12 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Hopewisper Dec. 4 at 11:05 PM

$TEVA Upppsss....

0 · Reply

Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 30, 2025, 3:14 AM EST - 7 days ago

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

INSM NTRA

Nov 25, 2025, 8:10 AM EST - 12 days ago

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Nov 21, 2025, 4:30 PM EST - 15 days ago

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December

Nov 19, 2025, 8:07 AM EST - 18 days ago

Teva seeks startups to help solve global pharmaceutical challenges

Nov 18, 2025, 8:58 AM EST - 19 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 14, 2025, 10:38 AM EST - 23 days ago

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Nov 11, 2025, 3:51 AM EST - 26 days ago

Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023

Nov 10, 2025, 2:51 PM EST - 26 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 7, 2025, 6:00 PM EST - 4 weeks ago

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Nov 5, 2025, 5:53 PM EST - 4 weeks ago

Why Teva Pharmaceutical Stock Rocked the Market Today

Nov 5, 2025, 1:02 PM EST - 4 weeks ago

Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working

Nov 5, 2025, 1:01 PM EST - 4 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 11:30 AM EST - 4 weeks ago

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Nov 5, 2025, 9:14 AM EST - 4 weeks ago

Teva Pharmaceuticals stock surges 12% as branded drug sales outperform

Nov 5, 2025, 7:44 AM EST - 4 weeks ago

Teva Pharm third-quarter profit tops estimates as branded drugs gain

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Nov 3, 2025, 10:55 AM EST - 4 weeks ago

Here's Why This Israeli Investment Giant Is Betting $834 Million on Teva Stock

Oct 31, 2025, 4:30 PM EDT - 5 weeks ago

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Oct 30, 2025, 11:45 AM EDT - 5 weeks ago

Blood pressure medicine recalled over high levels of cancer-causing chemical

Oct 29, 2025, 1:01 PM EDT - 5 weeks ago

Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

Oct 20, 2025, 4:30 PM EDT - 6 weeks ago

Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe

Oct 17, 2025, 12:18 PM EDT - 7 weeks ago

Teva Vs. Viatris: Who Will Dominate In President Trump's America?

VTRS

Oct 13, 2025, 4:10 AM EDT - 7 weeks ago

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2026

Oct 10, 2025, 3:00 PM EDT - 2 months ago

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Oct 7, 2025, 4:07 AM EDT - 2 months ago

Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside

Oct 6, 2025, 3:06 AM EDT - 2 months ago

Billionaire Stanley Druckenmiller Sold His Fund's Stakes in Nvidia and Palantir, and Has Piled Into These 2 Phenomenal Stocks for 4 Straight Quarters

TSM

Sep 25, 2025, 4:30 PM EDT - 2 months ago

Teva Releases Q3 2025 Aide Memoire

Sep 25, 2025, 4:30 PM EDT - 2 months ago

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

Sep 25, 2025, 11:42 AM EDT - 2 months ago

Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors

Sep 24, 2025, 7:23 AM EDT - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 22, 2025, 2:53 PM EDT - 2 months ago

Teva Pharmaceutical Industries Limited - Special Call

Sep 20, 2025, 10:15 PM EDT - 2 months ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Sep 17, 2025, 8:00 AM EDT - 2 months ago

Medincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 Presentation

Sep 16, 2025, 4:30 PM EDT - 2 months ago

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

Sep 9, 2025, 12:57 PM EDT - 3 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 5, 2025, 3:57 PM EDT - 3 months ago

Colorado must face Teva's lawsuit over free allergy pen law

Sep 2, 2025, 4:30 PM EDT - 3 months ago

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

Aug 28, 2025, 9:17 AM EDT - 3 months ago

US FDA approves Teva Pharmaceuticals' generic obesity drug

Aug 28, 2025, 1:43 AM EDT - 3 months ago

Teva's Pivot To (Innovative) Growth: Re-Rating Should Continue

Aug 20, 2025, 3:51 AM EDT - 3 months ago

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters

Aug 19, 2025, 9:00 AM EDT - 3 months ago

Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth”

Aug 5, 2025, 6:16 PM EDT - 4 months ago

US FDA approves Teva's Ajovy for migraine prevention in children

Jul 31, 2025, 3:27 PM EDT - 4 months ago

Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside

Jul 30, 2025, 12:40 PM EDT - 4 months ago

Teva CEO: Our supply chain puts us in a strong position

Jul 30, 2025, 11:50 AM EDT - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:21 AM EDT - 4 months ago

Teva Pharm Q2 profit beats estimates as branded drugs gain

Jul 29, 2025, 2:44 PM EDT - 4 months ago

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Jul 18, 2025, 3:06 AM EDT - 5 months ago

Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters

PLTR TSM

Jun 26, 2025, 4:30 PM EDT - 5 months ago

Teva Releases Q2 2025 Aide Memoire

Hshshhssos Dec. 6 at 5:04 PM

1 · Reply

SdotRayborn Dec. 6 at 3:55 AM

$TEVA TEVA RISE some believe in omens over silly charts tick tock👀👀

0 · Reply

LakersandVRX Dec. 5 at 10:11 PM

$TEVA Rooster is waiting for this to tank (along with his followers). It would be nice if he was wrong. Not hating on Rooster but everyone needs a douse of humbling...once in a while.

1 · Reply

TRADEADDICTNOMORE Dec. 5 at 6:49 PM

$TEVA thi

0 · Reply

SdotRayborn Dec. 5 at 6:37 PM

$TEVA nice

0 · Reply

WAJeff Dec. 5 at 6:01 PM

0 · Reply

thinkandpick Dec. 5 at 5:23 PM

0 · Reply

JarvisFlow Dec. 5 at 3:02 PM

Scotiabank updates rating for Teva Pharmaceutical Indus ( $TEVA ) to Outperform, target set at 35.

0 · Reply

OfficialStocktwitsUser Dec. 5 at 12:46 PM

0 · Reply

Hopewisper Dec. 4 at 11:05 PM

$TEVA Upppsss....

0 · Reply

Hopewisper Dec. 4 at 10:49 PM

$TEVA Tjek den her video: "what a wonderful world" https://share.google/Jn8u3at9AFe8S9QSc

0 · Reply

SdotRayborn Dec. 4 at 10:05 PM

$TEVA give me another gap up 😂

0 · Reply

LakersandVRX Dec. 4 at 9:06 PM

$TEVA every sell is being bought up. This has to be institutional buyers. This is going to be a holding in every value and growth fund.

1 · Reply

JawadAbuJaber Dec. 4 at 8:52 PM

$TEVA $30 calling?🚀

0 · Reply

SdotRayborn Dec. 4 at 8:46 PM

$TEVA 😂😂

0 · Reply

Hopewisper Dec. 4 at 8:42 PM

$TEVA past.... xx moving in.

0 · Reply

TheDudeRooster Dec. 4 at 8:31 PM

$TEVA Damn. No Christmas for the bears. You guys can’t share? 😂

1 · Reply

QuantInsider Dec. 4 at 8:14 PM

What's up with $TEVA Big 5-day rally, up 6.76% That $438.9k Dec 19 call block at the ask is pushing a bullish vibe into December But today’s flow was all puts, 7,574 contracts in Mar 20 26 $22S Looks like some protection into strength, not a bearish signal Plus, management's chat at Citi’s Healthcare Conference could stir things up Keep an eye on that IV

0 · Reply

ProfitMafia Dec. 4 at 7:53 PM

I’m looking at another $TEVA PLAY

0 · Reply

FinSUN Dec. 4 at 7:05 PM

$TEVA next selling block just below $30

0 · Reply

Hopewisper Dec. 4 at 7:03 PM

$TEVA Terradump =TheDudeRooster... grill the stupid assss....

1 · Reply

Nomorelies Dec. 4 at 6:30 PM

$TEVA last earnings were excellent. Headed up!

0 · Reply

Market Cap	32.64B
Revenue (ttm)	16.54B
Net Income (ttm)	-1.64B
EPS (ttm)	N/A
PE Ratio	10.79
Forward PE	10.99
Profit Margin	-9.91%
Debt to Equity Ratio	2.31

Volume	8,529,500
Avg Vol	11,427,544
Day's Range	N/A - N/A
Shares Out	1.15B
Stochastic %K	95%
Beta	0.67
Analysts	Strong Sell
Price Target	$26.89